Texas Heart Institute Discovery targets inflammatory disease for patients suffering from IBD (IMAGE)

Texas Heart Institute

Texas Heart Institute Discovery targets inflammatory disease for patients suffering from IBD

Caption

Aviara Pharmaceuticals, Inc. to collaborate with the Texas Heart Institute (THI) to develop a small molecule drug that targets inflammatory cell trafficking to the gut as a safe alternative to current treatment strategies in inflammatory bowel disease (IBD).

Credit

Photo Credit: Texas Heart Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.